The efficiency of Bonviva (Ibadronate) in women with pre-post menopause.

Aim: our aim was to see the efficiency of Bonviva(Ibadronates) among in osteoporoses among women.

Objectives: We chose this medicament which has the most acceptable price by all the GDP women's family and also this medicament which is at the new line of biphosphonate (Ibadronates), and has the most commodity of taken ones per monthly. For our proposal we include in our study all women age 45 -60 years old (average 52.